IQVIA Holdings Inc. is closing in on a roughly $1.1 billion takeover of Quotient Sciences, as the US clinical research group looks to expand its role in bringing new medicines to market.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.
